ABVC BioPharma, Inc. (ABVC) vs Baird Medical Investment Holdings Limited (BDMD)

A side-by-side comparison of ABVC BioPharma, Inc. and Baird Medical Investment Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ABVC

ABVC BioPharma, Inc.

$25M

$0.98HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

BDMD

Baird Medical Investment Holdings Limited

$31M

$0.74HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ABVC vs BDMD

growth of $100 · dividends reinvested · last 5y

ABVC -96.8% (-49.8%/yr)BDMD -92.3% (-40.1%/yr)BDMD compounded faster over this window

ABVC BDMD

ABVC vs BDMD: by the numbers

•BDMD is the larger company ($31M vs $25M market cap).
•Both run net losses; ABVC's is the smaller (0.00% vs -121.04% net margin).

Metrics side by side

Valuation

Metric	ABVC	BDMD
Forward P/E	N/A	9.29
P/B ratio	2.48	0.90

Profitability

Metric	ABVC	BDMD
Gross margin	0.00%	83.79%
Operating margin	0.00%	-113.31%
Net margin	0.00%	-121.04%
ROE	-76.82%	-86.96%
ROIC	-53.34%	-50.66%

Growth (annualized)

Metric	ABVC	BDMD
Revenue CAGR (5Y)	N/A	4.46%
Total return CAGR (5Y)	-46.33%	N/A

Go deeper

Full ABVC analysis Full BDMD analysis Interactive comparison tool

Dig into the metrics

ABVC BioPharma ROE Baird Medical Investment ROE ABVC BioPharma operating margin Baird Medical Investment operating margin ABVC BioPharma revenue growth Baird Medical Investment revenue growth ABVC BioPharma free cash flow Baird Medical Investment free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.